Literature DB >> 7738736

Sclerotherapy for venous malformations.

A A de Lorimier1.   

Abstract

Of the congenital vascular abnormalities, venous malformations receive little attention and essentially no discussion of treatment. The author describes a 30-year experience with sclerotherapy, which was used for 34 venous malformations. In some cases, these lesions are localized and can be excised, but all the patients in this series had such extensive involvement of adjacent organ systems that no other treatment than sclerotherapy was tenable. Five patients had Klippel-Trenaunay Syndrome, five had head and neck involvement, two had involvement of the entire left side and the remainder had other areas affected. Sodium morrhuate, ethanolamine, sotradecol, and absolute ethyl alcohol were the sclerosing agents used. A butterfly needle was inserted into an anomalous vein, and a three-way stopcock connected to saline and the sclerosing solution was used to ensure intraluminal injection. When rapid runoff into normal venous tributaries could be a concern, a venogram on the operating table preceded injection of the sclerosing solution. Small lesions required only one treatment; widespread bulky lesions required more than 30 injections. The volume of sclerosing solution varied from 5 to 90 mL per injection course. Because of pain, general anesthesia and an overnight hospital stay were necessary. Patients with pharyngeal and/or laryngeal involvement required preliminary tracheostomy or endotracheal ventilatory support for 3 days. Complications included skin necrosis, transient nerve palsy, hemoglobinuria, and one case of anaphylaxis. Repeated aggressive treatment was required for the very large malformations because recanalization occurred. All the patients have been very satisfied with the results.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7738736     DOI: 10.1016/0022-3468(95)90558-8

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  32 in total

1.  Treatment of oral hemangioma with 3% sodium tetradecyl sulfate: study of 20 cases.

Authors:  Sunita Agarwal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-04-13

2.  Sclerotherapy for venous malformations using a "negative subtraction" technique.

Authors:  Ronit Agid; Ram Burvin; John M Gomori
Journal:  Neuroradiology       Date:  2005-12-22       Impact factor: 2.804

3.  Acute compartment syndrome after sclerotherapy for a low-flow vascular malformation.

Authors:  Kelly L Apostle; Manraj K S Heran; Stephen J Tredwell
Journal:  Can J Surg       Date:  2008-06       Impact factor: 2.089

4.  Treatment of venous malformations with ethanolamine oleate: a descriptive study of 83 cases.

Authors:  Shafiqul Hoque; Bijoy Krishna Das
Journal:  Pediatr Surg Int       Date:  2011-05       Impact factor: 1.827

5.  Complications of embolization.

Authors:  José I Bilbao; Antonio Martínez-Cuesta; Femín Urtasun; Octavio Cosín
Journal:  Semin Intervent Radiol       Date:  2006-06       Impact factor: 1.513

6.  Cervicofacial venous malformations. MRI features and interventional strategies.

Authors:  O Konez; P E Burrows; J B Mulliken
Journal:  Interv Neuroradiol       Date:  2004-10-20       Impact factor: 1.610

Review 7.  Imaging of head and neck venous malformations.

Authors:  Christine M Flis; Stephen E Connor
Journal:  Eur Radiol       Date:  2005-07-08       Impact factor: 5.315

8.  Embolization of vascular malformations in head and neck regions. A single center experience.

Authors:  A Churojana; P Chiewwit; A Chuangsuwanich; C Aojanepong; O Chawalaparit; S Suthipongchai
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

Review 9.  Vascular anomalies: classification, imaging characteristics and implications for interventional radiology treatment approaches.

Authors:  P R Mulligan; H J S Prajapati; L G Martin; T H Patel
Journal:  Br J Radiol       Date:  2014-03       Impact factor: 3.039

10.  Venous malformations: MR imaging features that predict skin burns after percutaneous alcohol embolization procedures.

Authors:  Laura M Fayad; Tuncay Hazirolan; John A Carrino; David A Bluemke; Sally Mitchell
Journal:  Skeletal Radiol       Date:  2008-06-25       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.